AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 157 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $221 | +268.3% | 52,455 | +21.2% | 0.00% | +200.0% |
| Q1 2023 | $60 | -100.0% | 43,282 | -30.5% | 0.00% | -50.0% |
| Q3 2022 | $126,000 | +70.3% | 62,243 | +300.4% | 0.00% | – |
| Q4 2021 | $74,000 | -64.6% | 15,547 | -60.3% | 0.00% | -100.0% |
| Q3 2021 | $209,000 | +80.2% | 39,120 | +127.8% | 0.00% | 0.0% |
| Q1 2021 | $116,000 | +34.9% | 17,170 | -9.0% | 0.00% | – |
| Q4 2020 | $86,000 | -68.8% | 18,876 | -67.4% | 0.00% | -100.0% |
| Q2 2020 | $276,000 | +93.0% | 57,907 | +40.6% | 0.00% | +100.0% |
| Q1 2020 | $143,000 | +95.9% | 41,196 | +170.6% | 0.00% | 0.0% |
| Q4 2019 | $73,000 | +135.5% | 15,224 | +40.4% | 0.00% | – |
| Q3 2019 | $31,000 | -98.4% | 10,844 | -95.9% | 0.00% | -100.0% |
| Q2 2019 | $1,906,000 | +892.7% | 265,834 | +1776.4% | 0.01% | +550.0% |
| Q4 2018 | $192,000 | +60.0% | 14,167 | +93.0% | 0.00% | +100.0% |
| Q2 2018 | $120,000 | – | 7,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |